VertexBio
Finnrick has tested 8 samples from VertexBio across 0 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 7 | 17 Jun 2026 | 18 Aug 2026 | |||||
The VertexBio samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 14 overall satisfaction reports
People who submitted test requests to Finnrick gave VertexBio an average satisfaction rating of 4.9 out of 5 across 14 reports associated with samples received and tested by Finnrick.
Most recent VertexBio tests
Samples are tested in commercial labs
tests
products
Scores
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 18 Aug 2026 | Retatrutide | View | 5mg | ⚠️ Sample does not contain Retatrutide | n/a | Ret-26031501 | (no data) | Lab G | Public | |||
| 12 Aug 2026 | Retatrutide | View | 5mg | ⚠️ Sample does not contain Retatrutide | n/a | RET-26031501 | No label / Copper crimp / White cap | Lab E | Public | |||
| 4 Aug 2026 | Retatrutide | View | 5mg | 3.55mg | -29.0% | 98.20% | low | (no batch ID) | No label / Silver crimp / Green cap | Lab E | Public | |
| 3 Aug 2026 | Retatrutide | View | 30mg | ⚠️ Sample does not contain Retatrutide | n/a | RET-26031501 | No Label / Copper Crimp / White Cap | Lab E | Public | |||
| 9 Jul 2026 | Retatrutide | View | Endotoxins | 10mg | n/a | n/a | n/a | low | (no batch ID) | No label / Copper crimp / White cap | Lab G | Public |
| 9 Jul 2026 | Retatrutide | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | (no batch ID) | No label / Copper crimp / White cap | Lab G | Public | |||
| 22 Jun 2026 | Retatrutide | View | 50mg | ⚠️ Sample does not contain Retatrutide | below LOQ | (no batch ID) | No label / Silver crimp / Blue cap | Lab E | Public | |||
About VertexBio Test Results From Finnrick
VertexBio is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 0 products and 8 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
VertexBio Testing Activity & Score Summary
In the past 30 days, Finnrick has published 4 new test results for VertexBio, and 8 in the past three months. The overall dataset includes 8 tested samples with an average score of 1.2/10 across all products.
Across 7 identity-tested samples, 14% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 98.2%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products:
- Retatrutide (7 tests, 14% identity pass, median purity 98.2%) — Test scores are highly variable, ranging from 0.0 to 2.1 (average 1.2/10), suggesting significant batch-to-batch differences.